Joint Shantou International Eye Center of Shantou University and the Chinese University of Hong Kong, 69 North Dongxia Rd, Shantou, 515041, Guangdong, China.
BMC Ophthalmol. 2022 Jul 4;22(1):293. doi: 10.1186/s12886-022-02508-6.
Capillary non-perfusion is an important characteristic for diabetic retinopathy (DR) indicating microvascular damage and ischemia. Data on the description and treatment outcomes of DR with large area of non-perfusion are lacking to date. We aim to describe the characteristics and treatment outcomes in a series of patients with DR who presented extensively large area of capillary non-perfusion (LACNP).
Fundus fluorescein angiograms from medical charts in patients diagnosed with DR between Jan 2017 and Dec 2019 were retrospectively reviewed. Clinical data in eyes with LACNP including imaging and laboratory findings at the first presentation were analyzed. The LACNP was defined as over 70% area of capillary non-perfusion throughout the whole image retina. The mean follow-up duration was 12.4 ± 16.7 months. Follow-up data including extensive pan-retinal photocoagulation and surgical intervention and treatment outcomes were evaluated.
A total of 43 eyes in 24 patients with LACNP were included, accounting for 3.3% of DR populations in the same period. The overall percentage of non-perfusion area was 79.1 ± 8.1%. All patients received proper control of diabetes and hypertension, and extensive pan-retinal laser photocoagulation. During the follow-up periods, 20 eyes (46.5%) developed severe neovascular complications, of which 15 eyes (34.9%) underwent vitrectomy and/or anti-glaucoma surgeries. Conservative therapies including glycemic control and supplemental laser photocoagulation were conducted in 23 eyes (53.5%) without neovascular complications. In the final follow-up, best corrected visual acuity improved or maintained stable in 19 eyes (44.2%) while deteriorated in 24 eyes (55.8%).
The presence of LACNP is the hallmark of advanced DR and often indicates a poor visual outcome, although aggressive treatments may slow DR progression and maintain central vision for some time.
毛细血管无灌注是糖尿病视网膜病变(DR)的一个重要特征,表明存在微血管损伤和缺血。目前缺乏关于大面积无灌注(LACNP)DR 的描述和治疗结果的数据。我们旨在描述一系列广泛出现 LACNP 的 DR 患者的特征和治疗结果。
回顾性分析 2017 年 1 月至 2019 年 12 月期间被诊断为 DR 的患者病历中的眼底荧光素血管造影图像。分析首次就诊时 LACNP 眼的临床数据,包括影像学和实验室检查结果。将 LACNP 定义为整个视网膜图像中超过 70%的毛细血管无灌注区域。平均随访时间为 12.4±16.7 个月。评估了广泛全视网膜光凝和手术干预以及治疗结果的随访数据。
共纳入 24 例患者的 43 只眼出现 LACNP,占同期 DR 患者的 3.3%。无灌注区总面积为 79.1±8.1%。所有患者均接受了适当的糖尿病和高血压控制以及广泛的全视网膜激光光凝治疗。在随访期间,20 只眼(46.5%)发生严重的新生血管并发症,其中 15 只眼(34.9%)接受了玻璃体切除术和/或抗青光眼手术。23 只眼(53.5%)未发生新生血管并发症,采用保守治疗,包括血糖控制和补充激光光凝。最终随访时,19 只眼(44.2%)的最佳矫正视力改善或稳定,而 24 只眼(55.8%)的视力恶化。
LACNP 的存在是 DR 晚期的标志,通常预示着预后不良,尽管积极治疗可能会减缓 DR 的进展并在一段时间内维持中心视力。